📰 Scientific Session News
Page 5 - Scientific Session News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Scientific Session. Real-time updates on events, politics, business and more.
June 30, 2023
Pegozafermin was associated with improvements in fibrosis and could contribute to a resolution of NASH, according to the results of the phase 2b ENLIVEN trial.
June 26, 2023
A tablet form of semaglutide for weight loss showed positive results in phase 3 clinical trials, researchers announced at the American Diabetes Association (ADA) Scientific Session in Los Angeles, California.
June 14, 2023
Fairfax, VA (PRWEB) June 14, 2023 -- Rob S.B. Beanlands, MD, MASNC, deputy director general of the University of Ottawa Heart Institute and internationally
June 13, 2023
/PRNewswire/ -- AEYE Health, a leading provider of AI-based diagnostic screening solutions, is thrilled to announce the appointment of Guillermo Umpierrez, MD,...
April 26, 2023
The 2023 Society of Breast Imaging (SBI) Breast Imaging Symposium, SBI 2023, is set for May 4-7 at the Gaylord National Resort & Convention Center in National Harbor, Maryland. The in-person-only event theme, “Advancing What’s Possible: Better Every Day,” underscores the focus of the program schedule, as symposium planners promote the opportunities to explore ways to advance patient care, including those underserved, enhance their practice and boost both careers and self-care.
April 12, 2023
/PRNewswire/ -- Evermed and the American College of Cardiology (ACC) have announced the launch of ACC Anywhere, a new content hub that provides cardiologists...
March 31, 2023
Erin Michos, MD, MHS, opens a discussion surrounding the utilization of bempedoic acid for patients with intolerance to statin-based therapies.
March 31, 2023
Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases , which amended... | March 31, 2023
March 30, 2023
LONDON and SALT LAKE CITY, March 30, 2023 -- Renalytix plc , an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive... | March 30, 2023
March 30, 2023
The hub contains original content from five conferences including ACC’s 2022 and 2023 Annual Scientific Session, with additional conferences to be added in the future